Trials / Completed
CompletedNCT06736366
Study With Two Coenzyme Q10 Products
Comparative Single-dose Bioavailability Clinical Study of Two Different Coenzyme Q10 Products
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 25 (actual)
- Sponsor
- University of Primorska · Academic / Other
- Sex
- All
- Age
- 50 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products
Detailed description
The randomized, open-label, two period crossover single-dose bioavailability study with two coenzyme Q10 products will include 35 subjects who will test two different coenzyme Q10 products. Plasma concentration of coenzyme Q10 will be measured.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Dietary supplement - Active comparator | Single dose intervention with Standard product Coenzyme Q10 (ubiquinone); 2 capsules - 100 mg total coenzyme Q10 |
| DIETARY_SUPPLEMENT | Dietary supplement - Experimental product | Single dose intervention with Experimental product; BMT® coenzyme Q10; 2 capsules - 100 mg total coenzyme Q10 |
Timeline
- Start date
- 2024-12-05
- Primary completion
- 2024-12-16
- Completion
- 2025-06-30
- First posted
- 2024-12-16
- Last updated
- 2025-12-05
Locations
1 site across 1 country: Slovenia
Source: ClinicalTrials.gov record NCT06736366. Inclusion in this directory is not an endorsement.